(-)-epigallocatechin 3-gallate/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Inhibits EGFR
SpeculativeGrade F, Speculative. Mechanistic inference, no evidence found, or evidence weakened below D.Finding“EGCG also suppressed EGFR expression, especially in Hep3BLR.”
Quoted verbatim from Antitumor Potential of Epigallocatechin Gallate in Overcoming Molecular Therapy Resistance in Hepatocellular Carcinoma.. - Study
- in vitro · not in humans
- Dose
- 10 μg/ml
- Population
- Hep3B human hepatocellular carcinoma cells and the lenvatinib-resistant Hep3BLR subline
Antitumor Potential of Epigallocatechin Gallate in Overcoming Molecular Therapy Resistance in Hepatocellular Carcinoma.2025PMID:41006034Permalink
Keep reading
- Everything the graph holds on (-)-epigallocatechin 3-gallate
- Every compound studied against EGFR
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M3J952K7ZA0HWZ0GWP31FAPQ